This company listing is no longer active
Endo International Dirección
Dirección controles de criterios 3/4
El CEO de Endo International's es Blaise Coleman , nombrado en Dec 2016, tiene una permanencia de 7.33 años. compensación anual total es $12.85M, compuesta por 7.6% salario y 92.4% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.18% de las acciones de la empresa, por valor de $253.23. La antigüedad media del equipo directivo y de la junta directiva es de 4.8 años y 7 años, respectivamente.
Información clave
Blaise Coleman
Chief Executive Officer (CEO)
US$12.8m
Compensación total
| Porcentaje del salario del CEO | 7.6% |
| Permanencia del CEO | 7.4yrs |
| Participación del CEO | 0.2% |
| Permanencia media de la dirección | 4.8yrs |
| Promedio de permanencia en la Junta Directiva | 7yrs |
Actualizaciones recientes de la dirección
Recent updates
Endo creditors looking at putting company up for sale through bankruptcy - Bloomberg
Aug 16Endo International sees 23% rise on 3x higher than normal volume
Aug 03Endo outperforms defying bankruptcy fears and generic entry
Jul 25Endo weighs bankruptcy filing without opioid settlement - WSJ
Jul 12Endo International cools off, giving back some of its 85% Tuesday gain
Jun 29Endo: Stick A Fork In It
May 10Endo: About As Bad As It Gets
Mar 07Endo: FDA Approves Generic Form Of Vasostrict Creating Headwind Into Next Year
Dec 16Endo: A Win In California But Equity Value Still A Question
Nov 02Endo International: Loses Vasostrict Trial
Aug 31Endo International: Hires Restructuring Advisor
Aug 20Endo International: All About Ongoing Litigation
Aug 07Endo: Appellate Court Denies Request To Postpone Damages Trial Might Be End O' The Road
Jul 15Endo International: Bankruptcy Seems Like The Only Practical Option
Jun 30Endo International wins FDA approval for Micafungin new formulation
Jun 17Endo International plc 2021 Q1 - Results - Earnings Call Presentation
May 07Radius Health partners with Endo unit for abaloparatide in Canada
Jan 05Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$2b |
| Sep 30 2023 | n/a | n/a | -US$252m |
| Jun 30 2023 | n/a | n/a | -US$942m |
| Mar 31 2023 | n/a | n/a | -US$3b |
| Dec 31 2022 | US$13m | US$978k | -US$3b |
| Sep 30 2022 | n/a | n/a | -US$3b |
| Jun 30 2022 | n/a | n/a | -US$3b |
| Mar 31 2022 | n/a | n/a | -US$681m |
| Dec 31 2021 | US$29m | US$913k | -US$569m |
| Sep 30 2021 | n/a | n/a | US$129m |
| Jun 30 2021 | n/a | n/a | US$109m |
| Mar 31 2021 | n/a | n/a | US$137m |
| Dec 31 2020 | US$7m | US$829k | US$247m |
| Sep 30 2020 | n/a | n/a | -US$102m |
| Jun 30 2020 | n/a | n/a | -US$75m |
| Mar 31 2020 | n/a | n/a | -US$190m |
| Dec 31 2019 | US$4m | US$612k | -US$361m |
| Sep 30 2019 | n/a | n/a | -US$418m |
| Jun 30 2019 | n/a | n/a | -US$522m |
| Mar 31 2019 | n/a | n/a | -US$477m |
| Dec 31 2018 | US$3m | US$569k | -US$962m |
| Sep 30 2018 | n/a | n/a | -US$968m |
| Jun 30 2018 | n/a | n/a | -US$921m |
| Mar 31 2018 | n/a | n/a | -US$2b |
| Dec 31 2017 | US$4m | US$546k | -US$1b |
Compensación vs. Mercado: La compensación total de Blaise($USD12.85M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD668.06K).
Compensación vs. Ingresos: La compensación de Blaise ha sido consistente con los resultados de la empresa en el último año.
CEO
Blaise Coleman (49 yo)
7.4yrs
Permanencia
US$12,849,847
Compensación
Mr. Blaise A. Coleman serves as President, Chief Executive Officer and Director of Endo Inc. Mr. Blaise serves as President, Chief Executive Officer and Director at Endo International plc since March 06, 2...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 7.4yrs | US$12.85m | 0.18% $ 253.2 | |
| Executive VP | 9yrs | US$4.25m | 0.15% $ 210.7 | |
| Executive Vice President of Global Research & Development | 2.3yrs | US$6.36m | sin datos | |
| Executive VP & CFO | 4.2yrs | US$7.98m | sin datos | |
| VP, Controller & Chief Accounting Officer | no data | sin datos | sin datos | |
| Senior VP of Information Technology & Chief Information Officer | 1.9yrs | sin datos | sin datos | |
| Senior Vice President of Investor Relations & Corporate Affairs | 5.8yrs | sin datos | sin datos | |
| Senior VP & Chief Compliance Officer | 6.1yrs | sin datos | sin datos | |
| Chief Human Resources Officer | 4.8yrs | sin datos | sin datos | |
| Executive VP & President of Global Commercial Operations | 7.4yrs | US$7.78m | sin datos | |
| Head of Endo Ventures Limited & Senior VP of Global Supply Chain | 3.5yrs | sin datos | sin datos | |
| Global Head of Quality & Compliance | 1.9yrs | sin datos | sin datos |
4.8yrs
Permanencia media
54yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de ENDP.Q se considera experimentado (4.8 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 4.2yrs | US$12.85m | 0.18% $ 253.2 | |
| Independent Chairman | 4.3yrs | US$840.00k | 0.016% $ 22.9 | |
| Independent Director | 10.3yrs | US$625.00k | 0.15% $ 213.3 | |
| Independent Director | 10.3yrs | US$625.00k | 0.042% $ 59.3 | |
| Independent Director | 9.8yrs | US$505.00k | 0.043% $ 60.0 | |
| Independent Director | 3.3yrs | US$480.00k | 0.011% $ 14.9 | |
| Independent Director | 10.3yrs | US$505.00k | 0.047% $ 65.8 | |
| Independent Non-Executive Director | 3.8yrs | US$480.00k | 0.014% $ 19.7 |
7.0yrs
Permanencia media
61yo
Promedio de edad
Junta con experiencia: La junta directiva de ENDP.Q se considera experimentada (7 años de antigüedad promedio).